Force Control Deficits in Individuals with Parkinson's Disease, Multiple Systems Atrophy, and Progressive Supranuclear Palsy

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Neely, Kristina A ^a   Planetta, Peggy J ^a   Prodoehl, Janey ^b   Corcos, Daniel M ^c,d   Comella, Cynthia L ^e   Goetz, Christopher G ^e   Shannon, Kathleen L ^e   Vaillancourt, David E ^a,f  

^a UNIVERSITY OF FLORIDA   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d University of Illinois at Chicago   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; BRIEF TEST OF ATTENTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FORCE; FORCE CONTROL DEFICIT; FORCE PULSE; GRIP STRENGTH; HUMAN; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY; PULSE RATE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; TASK PERFORMANCE;

AGED; COGNITION; FEMALE; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; ROC CURVE; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84874916303     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058403     Document Type: Article

References (53)

1. Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, et al. (2005) Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. Neurology 64: 87-93.
2. Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, et al. (2010) Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet neurology 9: 149-158.
3. Wenning GK, Litvan I, Tolosa E, (2011) Milestones in atypical and secondary Parkinsonisms. Movement disorders: official journal of the Movement Disorder Society 26: 1083-1095.
4. Freund HJ, Budingen HJ, (1978) The relationship between speed and amplitude of the fastest voluntary contractions of human arm muscles. Experimental brain research Experimentelle Hirnforschung Experimentation cerebrale 31: 1-12.
5. Gordon J, Ghez C, (1987) Trajectory control in targeted force impulses. II. Pulse height control. Experimental brain research Experimentelle Hirnforschung Experimentation cerebrale 67: 241-252.
6. Fellows SJ, Noth J, (2004) Grip force abnormalities in de novo Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society 19: 560-565.
7. Fellows SJ, Noth J, Schwarz M, (1998) Precision grip and Parkinson's disease. Brain: a journal of neurology 121 (Pt 9): 1771-1784.
8. Jordan N, Sagar HJ, Cooper JA, (1992) A component analysis of the generation and release of isometric force in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry 55: 572-576.
9. Stelmach GE, Worringham CJ, (1988) The preparation and production of isometric force in Parkinson's disease. Neuropsychologia 26: 93-103.
10. Park JH, Stelmach GE, (2007) Force development during target-directed isometric force production in Parkinson's disease. Neuroscience letters 412: 173-178.
11. Corcos DM, Chen CM, Quinn NP, McAuley J, Rothwell JC, (1996) Strength in Parkinson's disease: Relationship to rate of force generation and clinical status. Annals of Neurology 39: 79-88.
12. Robichaud JA, Pfann KD, Vaillancourt DE, Comella CL, Corcos DM, (2005) Force control and disease severity in Parkinson's disease. Movement Disorders 20: 441-450.
13. Muratori LM, Reilmann R, Gordon AM, (2003) Coordination of fingertip forces during precision grasping in multiple system atrophy. Neuropsychologia 41: 1498-1508.
14. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1-9.
15. Soliveri P, Monza D, Paridi D, Carella F, Genitrini S, et al. (2000) Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. Journal of neurology, neurosurgery, and psychiatry 69: 313-318.
16. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ, (2001) What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992. Neurology 57: S34-38.
17. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, et al. (1999) Consensus statement on the diagnosis of multiple system atrophy. Journal of the neurological sciences 163: 94-98.
18. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-1534.
19. Vaillancourt DE, Thulborn KR, Corcos DM, (2003) Neural basis for the processes that underlie visually guided and internally guided force control in humans. Journal of neurophysiology 90: 3330-3340.
20. Spraker MB, Corcos DM, Vaillancourt DE, (2009) Cortical and Subcortical Mechanisms for Precisely Controlled Force Generation and Force Relaxation. Cerebral cortex 19: 2640-2650.
21. Hallett M, Rothwell J, (2011) Milestones in clinical neurophysiology. Movement disorders: official journal of the Movement Disorder Society 26: 958-967.
22. Wichmann T, DeLong MR, Guridi J, Obeso JA, (2011) Milestones in research on the pathophysiology of Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society 26: 1032-1041.
23. Wichmann T, Dostrovsky JO, (2011) Pathological basal ganglia activity in movement disorders. Neuroscience 198: 232-244.
24. Prodoehl J, Spraker M, Corcos D, Comella C, Vaillancourt D, (2010) Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society 25: 2035-2043.
25. Fellows SJ, Kronenburger M, Allert N, Coenen VA, Fromm C, et al. (2006) The effect of subthalamic nucleus deep brain stimulation on precision grip abnormalities in Parkinson's disease. Parkinsonism & related disorders 12: 149-154.
26. Nowak DA, Topka H, Tisch S, Hariz M, Limousin P, et al. (2005) The beneficial effects of subthalamic nucleus stimulation on manipulative finger force control in Parkinson's disease. Experimental neurology 193: 427-436.
27. Vaillancourt DE, Prodoehl J, Verhagen Metman L, Bakay RA, Corcos DM, (2004) Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease. Brain: a journal of neurology 127: 491-504.
28. Aron AR, Monsell S, Sahakian BJ, Robbins TW, (2004) A componential analysis of task-switching deficits associated with lesions of left and right frontal cortex. Brain: a journal of neurology 127: 1561-1573.
29. Aron AR, Robbins TW, Poldrack RA, (2004) Inhibition and the right inferior frontal cortex. Trends in cognitive sciences 8: 170-177.
30. Dubois B, Slachevsky A, Pillon B, Beato R, Villalponda JM, et al. (2005) "Applause sign" helps to discriminate PSP from FTD and PD. Neurology 64: 2132-2133.
31. Pillon B, Blin J, Vidailhet M, Deweer B, Sirigu A, et al. (1995) The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 45: 1477-1483.
32. Luzzi S, Fabi K, Pesallaccia M, Silvestrini M, Provinciali L, (2013) Applause sign in Alzheimer's disease: relationships to cognitive profile and severity of illness. Journal of neurology 260(1): 172-175.
33. Luzzi S, Fabi K, Pesallaccia M, Silvestrini M, Provinciali L, (2011) Applause sign: is it really specific for Parkinsonian disorders? Evidence from cortical dementias. Journal of neurology, neurosurgery, and psychiatry 82: 830-833.
34. Wu LJ, Sitburana O, Davidson A, Jankovic J, (2008) Applause sign in Parkinsonian disorders and Huntington's disease. Movement disorders: official journal of the Movement Disorder Society 23: 2307-2311.
35. Ling H, Massey LA, Lees AJ, Brown P, Day BL, (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. Brain: a journal of neurology 135: 1141-1153.
36. Dutta C, Hadley EC (1995) The significance of sarcopenia in old age. The journals of gerontology Series A, Biological sciences and medical sciences 50 Spec No: 1-4.
37. Doherty TJ, (2003) Invited review: Aging and sarcopenia. Journal of applied physiology 95: 1717-1727.
38. Hughes VA, Frontera WR, Wood M, Evans WJ, Dallal GE, et al. (2001) Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. The journals of gerontology Series A, Biological sciences and medical sciences 56: B209-217.
39. Slifkin AB, Newell KM, (1999) Noise, information transmission, and force variability. Journal of experimental psychology Human perception and performance 25: 837-851.
40. Slifkin AB, Newell KM, (2000) Variability and noise in continuous force production. Journal of motor behavior 32: 141-150.
41. Sosnoff JJ, Newell KM, (2006) Are age-related increases in force variability due to decrements in strength? Experimental brain research Experimentelle Hirnforschung Experimentation cerebrale 174: 86-94.
42. Tracy BL, Maluf KS, Stephenson JL, Hunter SK, Enoka RM, (2005) Variability of motor unit discharge and force fluctuations across a range of muscle forces in older adults. Muscle & nerve 32: 533-540.
43. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, et al. (1995) Olfactory function in atypical parkinsonian syndromes. Acta neurologica Scandinavica 91: 247-250.
44. Berendse HW, Ponsen MM, (2009) Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging. Parkinsonism & related disorders 15Suppl 3: S26-30.
45. Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, et al. (2012) Phosphorylated alpha-synuclein in Parkinson's disease. Science translational medicine 4: 121ra120.
46. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, et al. (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain: a journal of neurology 133: 713-726.
47. Brooks DJ, (2008) Technology insight: imaging neurodegeneration in Parkinson's disease. Nature clinical practice Neurology 4: 267-277.
48. Antonini A, (2010) Imaging for early differential diagnosis of parkinsonism. Lancet neurology 9: 130-131.
49. Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, et al. (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72: 1378-1384.
50. Menke RA, Scholz J, Miller KL, Deoni S, Jbabdi S, et al. (2009) MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. NeuroImage 47: 435-441.
51. Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, et al. (2006) Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain: a journal of neurology 129: 538-542.
52. Dodel RC, Hoffken H, Moller JC, Bornschein B, Klockgether T, et al. (2003) Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach. Movement disorders: official journal of the Movement Disorder Society 18Suppl 7: S52-62.
53. Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, et al. (2005) Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain: a journal of neurology 128: 1605-1612.